T. Rowe Price Associates »

Foghorn Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Foghorn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Foghorn Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Foghorn Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $118k 25k 4.82
2025-12-31 $89k 16k 5.42
2025-09-30 $81k 16k 4.94
2025-06-30 $67k 14k 4.70

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Foghorn Therapeutics

Flagship Ventures Management
BVF
FMR
Deerfield Management Company
BlackRock
Raymond James Financial
Euclidean Capital
Vanguard Capital Management
Geode Capital Management
Siren
State Street Corporation
Ameriprise Financial
Renaissance Technologies
Candriam Luxembourg S.C.A.
Northern Trust

View all funds holding Foghorn Therapeutics